Effective treatment of a peripheral T-cell lymphoma/lymphoepitheloid cell variant (Lennert's lymphoma) refractory to chemotherapy with the CD-52 antibody alemtuzumab.

Zeitlinger, M A

Effective treatment of a peripheral T-cell lymphoma/lymphoepitheloid cell variant (Lennert's lymphoma) refractory to chemotherapy with the CD-52 antibody alemtuzumab. [electronic resource] - Leukemia & lymphoma May 2005 - 771-4 p. digital

Publication Type: Case Reports; Journal Article

1042-8194

10.1080/10428190400028959 doi


Aged
Alemtuzumab
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm--therapeutic use
Antigens, CD--immunology
Antigens, Neoplasm--immunology
Antineoplastic Agents--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
CD52 Antigen
Glycoproteins--immunology
Humans
Immunotherapy--methods
Lymphoma, T-Cell, Peripheral--drug therapy
Male